Status:
UNKNOWN
Intranasal Sedation With Dexmedetomidine
Lead Sponsor:
University Medical Centre Ljubljana
Conditions:
Conscious Sedation
Eligibility:
All Genders
18-70 years
Phase:
PHASE4
Brief Summary
For patients with eye surgery and shorter surgery, sedation is a well-established method in preserved consciousness and has been successfully used for several years. We have also developed and publish...
Detailed Description
For patients with eye surgery and shorter surgery, sedation is a well-established method in preserved consciousness and has been successfully used for several years. We have also developed and publish...
Eligibility Criteria
Inclusion
- patients who will be operated on the eye (vitreoretinal interventions) patients with ASA status 1-3
- \-
Exclusion
- patients who will not want to be operated in the sedation but in general anesthesia
- poor general condition (ASA\> 3)
- with severe cardiac disease (NYHA\> 3)
- with severe pulmonary obstructive disease (FEV1 \<40%)
- neurological diseases
- psychiatric patients
- patients receiving regular psychotropic treatment
Key Trial Info
Start Date :
January 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2018
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03251222
Start Date
January 1 2017
End Date
March 1 2018
Last Update
August 16 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UMCLjubljana, CD of Anaesthesiology and Intensive Therapy
Ljubljana, Slovenia, 1000